NuVasive, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

April 2024 | 50 pages | ID: NE3CC469E5EBEN
BAC Reports

Abstracts

NuVasive, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between NuVasive, Inc. and its competitors. This provides our Clients with a clear understanding of NuVasive, Inc. position in the Healthcare Equipment and Supplies Industry.

• The report contains detailed information about NuVasive, Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
• Another part of the report is a SWOT-analysis carried out for NuVasive, Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
• The NuVasive, Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
• In the part that describes NuVasive, Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
• Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of NuVasive, Inc. business.

About NuVasive, Inc.

NuVasive, Inc., a medical device company, engages in the design, development, and marketing of products for the surgical treatment of spine disorders. The company’s principal product offering includes a disruptive surgical platform called Maximum Access Surgery (MAS), as well as an offering of cervical, biologics and motion preservation products. Its products are used predominantly in spine fusion surgeries, both to enable access to the spine and to perform restorative and fusion procedures.

The NuVasive Solution — Maximum Access Surgery (MAS)

The company’s MAS platform allows surgeons to perform a range of disruptive procedures. Its MAS platform combines four product categories, such as NeuroVision, MaXcess, biologics, and specialized implants. NeuroVision enables surgeons to navigate around nerves and MaXcess affords direct customized access to the spine for implant delivery. MaXcess also allows surgeons to use traditional instruments in a minimally disruptive and less traumatic manner and its biologics offering compliments its MAS platform by facilitating fusion. The company also offers various specialized implants that enable structural support and conforming to the anatomical requirements of the patient.

MAS — NeuroVision

The company’s system functions by monitoring changes in electrical signals across muscle groups, which allows it to detect underlying changes in nerve activity. The company connects the instruments that surgeons use to a computer system that provides real time feedback during surgery. The system analyzes and then translates neurophysiologic data into useful information to assist the surgeon’s clinical decision-making process. In addition, during a pedicle screw test, in which the integrity of the bone where the implant is placed is tested, if the insertion of a screw results in a breach of the bone, a red light and corresponding numeric value results so that the surgeon may reposition the implant to avoid potential nerve impingement or irritation.

MAS — MaXcess

The company’s MaXcess system consists of instrumentation and specialized implants that provide maximum access to the spine with minimal soft tissue disruption. MaXcess’ split blade design also provides expanded access to the spine, which allows surgeons to perform surgical procedures using instruments that are similar to those used in open procedures and with a significantly smaller incision. The company’s system’s illumination of the operative corridor aids in providing surgeons with direct visualization of the patient’s anatomy, without the need for additional technology or other special equipment.

MAS — Specialized Implants

The company has various implants designed to be used with its MAS platform. These implants are used for interbody disc height restoration for fusion, partial vertebral body replacement and stabilization of the spine. Its implants are available in various shapes and sizes to accommodate the anatomical requirements of the patient and the particular fusion procedure. The company’s implants are designed for insertion into the smallest possible space while maximizing surface area contact for fusion. Its motion preservation product development efforts also include its mechanical lateral total disc replacement (XL TDR).

MAS — Biologics

As part of its MAS offering, the company has expanded its product offerings to include products in the biologics market. It made its initial entry into this market in 2007 by acquiring rights to FormaGraft, a collagen-based synthetic product. The company expanded this offering in 2008 by acquiring Osteocel, an allograft cellular matrix containing viable MSCs to aid in fusion. In 2009, it made an investment in Progentix Orthobiology BV, a private company working to develop a synthetic osteoinductive bone graft material.

Suppliers

The company's suppliers include Tissue Banks International, Inc., AlloSource, Inc., Pearsalls Limited, Osiris Therapeutics, Inc., Radius Medical, LLC, Maxigen Biotech, and Waldemar Link GmbH & Co. KG.

Competition

The company’s NeuroVision system competes with the conventional nerve monitoring systems offered by Medtronic Sofamor Danek (Medtronic), Cadwell, and Nicolet Biomedical. Various companies offer products that compete with its MaXcess system, SpheRx pedicle screw system and implants, including offerings by DePuy Spine, Inc. (Depuy), a Johnson & Johnson company, Medtronic, and Stryker Spine. In the fusion product market, the company competes with Medtronic, DePuy, Stryker Spine, and Synthes, Inc.

Competition in the motion preservation segment includes Medtronic, DePuy, Stryker Spine, and Synthes, Inc. In the cervical total disc replacement (TDR) segment, the company identifies competition from Medtronic’s Prestige and Bryan TDRs as well as Synthes, Inc.’s ProDisc TDR. The company competes with Globus Medical, Inc., Zimmer Spine, Orthofix International N.V. (Blackstone Medical, Inc.), Biomet EBI/Spine, and Alphatec Spine, Inc.

History

NuVasive, Inc. was founded in 1997.

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.

Contents

RESEARCH METHODOLOGY

DISCLAIMER

1. NUVASIVE, INC. COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. NUVASIVE, INC. BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. NUVASIVE, INC. SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. NUVASIVE, INC. FINANCIAL ANALYSIS

4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.1. Profitability
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. NUVASIVE, INC. COMPETITORS AND INDUSTRY ANALYSIS

5.1. NuVasive, Inc. Direct Competitors
5.2. Comparison of NuVasive, Inc. and Direct Competitors Financial Ratios
5.3. Comparison of NuVasive, Inc. and Direct Competitors Stock Charts
5.4. NuVasive, Inc. Industry Analysis
5.4.1. Healthcare Equipment and Supplies Industry Snapshot
  5.4.2. NuVasive, Inc. Industry Position Analysis

6. NUVASIVE, INC. NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. NUVASIVE, INC. EXPERTS REVIEW¹

7.1. Experts Consensus
7.2. Experts Revisions

8. NUVASIVE, INC. ENHANCED SWOT ANALYSIS²

9. UNITED STATES PESTEL ANALYSIS²

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. NUVASIVE, INC. IFE, EFE, IE MATRICES²

10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix

11. NUVASIVE, INC. PORTER FIVE FORCES ANALYSIS²

12. NUVASIVE, INC. VRIO ANALYSIS²

APPENDIX: RATIO DEFINITIONS

LIST OF FIGURES

NuVasive, Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
NuVasive, Inc. 1-year Stock Charts
NuVasive, Inc. 5-year Stock Charts
NuVasive, Inc. vs. Main Indexes 1-year Stock Chart
NuVasive, Inc. vs. Direct Competitors 1-year Stock Charts
NuVasive, Inc. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

List Of Tables

LIST OF TABLES

NuVasive, Inc. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
NuVasive, Inc. Key Executives
NuVasive, Inc. Major Shareholders
NuVasive, Inc. History
NuVasive, Inc. Products
Revenues by Segment
Revenues by Region
NuVasive, Inc. Offices and Representations
NuVasive, Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
NuVasive, Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
NuVasive, Inc. Capital Market Snapshot
NuVasive, Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Equipment and Supplies Industry Statistics
NuVasive, Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
NuVasive, Inc. Consensus Recommendations¹
Analyst Recommendation Summary¹
Price Target Summary¹
Experts Recommendation Trends¹
Revenue Estimates Analysis¹
Earnings Estimates Analysis¹
Historical Surprises¹
Revenue Estimates Trend¹
Earnings Estimates Trend¹
Revenue Revisions¹

ANALYSIS FEATURES

SWOT Analysis

SWOT, which stands for Strengths, Weaknesses, Opportunities and Threats, is an analytical framework that identifies the internal and external factors that are favorable and unfavorable for a company.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

• How to use the strengths to take advantage of the opportunities?
• How to use the strengths to reduce likelihood and impact of the threats?
• How to overcome the weaknesses that obstruct taking advantage of the opportunities?
• How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.

PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

• Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
• Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
• Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
• Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
• Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
• Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.

Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

1. What composes a threat of substitute products and services?
2. Is there a threat of new competitors entering the market?
3. What is the intensity of competitive rivalry?
4. How big is the bargaining power of buyers?
5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

• Tangible resources
  • Financial
  • Physical
  • Technological
  • Organizational
• Intangible resources
  • Human
  • Innovation and Creativity
  • Reputation
• Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

• Valuable?
• Rare?
• Costly to imitate?
• Organized properly?